Northwestern Mutual Wealth Management
RGLS

Northwestern Mutual Wealth Management’s Regulus Therapeutics RGLS Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-13
Closed -$5K – 1229
2016
Q2 		$5K Buy
+13
New +$9.31K ﹤0.01% 1602

Other funds holding RGLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northwestern Mutual Wealth Management's RGLS Position: Q3 2016 in Review

Northwestern Mutual Wealth Management sold out of Regulus Therapeutics (RGLS) in Q3 2016, closing a stake of 13 shares — an estimated $5K sold.

Northwestern Mutual Wealth Management first reported a position in RGLS in Q2 2016 and held it in 1 quarter. The position peaked at $5K in Q2 2016. 83 funds tracked by Wall St. Rank hold RGLS as of Q3 2016.

  • Northwestern Mutual Wealth Management reported no remaining Regulus Therapeutics position as of Q3 2016 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 13 Regulus Therapeutics shares in Q3 2016, an estimated $5K.
  • Northwestern Mutual Wealth Management first reported a position in Regulus Therapeutics in Q2 2016 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Regulus Therapeutics position peaked at $5K in Q2 2016.
  • 83 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q3 2016.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2016, filed 14 Nov 2016.